Quantcast

Latest Clinical research Stories

2014-06-10 08:31:06

First Site Opened In Late May, 7 More Sites Now Scheduled During June and July BETHESDA, Md., June 10, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that it has initiated the Phase III trial of DCVax-L in Germany. The first site to open in Germany was a medical center in Dresden, which was initiated in late May. The Company has now scheduled the...

2014-06-10 08:30:46

NEW YORK, June 10, 2014 /PRNewswire/ -- Intralinks® Holdings, Inc. (NYSE: IL), a leading, global SaaS provider of inter-enterprise content management and collaboration solutions, today announced the availability of its electronic investigator-controlled site file (eISF) solution, a simple online document storage tool for investigator sites involved in the clinical trial process. The new solution is designed to dramatically improve regulatory compliance and efficiency at the...

2014-06-10 08:29:23

-Consulting at Every Phase of the Product Life Cycle- SALT LAKE CITY, June 10, 2014 /PRNewswire/ -- Nelson Laboratories (www.nelsonlabs.com) announced today the expansion of its services with the addition of a dedicated Technical Consulting Services group for MedTech companies. Technical Consulting Services encompasses product development, facility and process validation, product performance testing, and regulatory support to help clients deliver medical devices to market that are safe and...

2014-06-10 08:29:19

SAN JOSE, Calif., June 10, 2014 /PRNewswire/ -- Pulsar Vascular, the innovator and developer of the PulseRider®, a minimally invasive, aneurysm neck reconstruction device, announced today the United States Food and Drug Administration (FDA)'s approval of an Investigational Device Exemption (IDE) for the PulseRider. The IDE allows Pulsar Vascular to begin a multicenter clinical trial in support of a Humanitarian Device Exemption (HDE) to evaluate the PulseRider for US approval for...

2014-06-09 23:10:54

d-Wise announced the availability of their Clinical Advisory and Modernization consulting capabilities, offering a progressive and comprehensive methodology for modernizing clinical trial processes and infrastructures. Morrisville, NC (PRWEB) June 09, 2014 d-Wise, the leading life science and healthcare technology consulting and solution provider, announced today they are rolling out new Clinical Advisory and Modernization consulting services at DIA, aimed squarely at Pharmaceutical...

2014-06-09 23:08:57

On May 22, the FDA announced that 56 lots of NaturaLyte Liquid Bicarbonate Concentrate 6.4 liters, by Fresenius Medical Care North America, are recalled because they may develop higher bacteria levels than is allowed. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 09, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest...

2014-06-09 14:39:26

Health Affairs Reducing Maternal Mortality In Zambia and Uganda. Margaret E. Kruk of Columbia University and co-authors assessed the effectiveness of Saving Mothers, Giving Life, a new global public-private partnership that aims to reduce maternal mortality in eight districts in Uganda and Zambia. They evaluated the first six to twelve months of the program's implementation, its ownership by national ministries of health, and its effects on health systems. According to the authors, early...

2014-06-09 12:31:09

ATLANTA, June 9, 2014 /PRNewswire/ -- Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, announces the approval of an Abbreviated New Drug Application (ANDA)(1) for Tranexamic Acid Injection 1000 mg/10mL (100 mg/mL). The Food and Drug Administration (FDA) determined that Acella's ANDA is bioequivalent - therefore, therapeutically equivalent - to the reference listed drug, CYKLOKAPRON® - Tranexamic Acid Injection Solution (Pharmacia & Upjohn, Inc.). Tranexamic Acid...

2014-06-09 12:30:55

RESEARCH TRIANGLE PARK, N.C., June 9, 2014 /PRNewswire/ -- Max Neeman International announced today that India's Ministry of Health released new and revised draft guidelines on compensation to be paid for medical management with regards to treatment of any injury related to clinical trial is now aligned with global standards. http://photos.prnewswire.com/prnvar/20110105/CL25129LOGO The new guidelines on medical management in clinical trial injury states that: -- In the case of an...

2014-06-09 08:29:23

GLEN BURNIE, Md., June 9, 2014 /PRNewswire/ -- CSSi, the leader in patient recruitment solutions for the clinical research industry, recently announced the formation of the company's Medical and Clinical Advisory Board (MCAB) and the appointment of Ronald M. Bukowski, MD as its chairman. Photo - http://photos.prnewswire.com/prnh/20140606/95194 The MCAB, with Dr. Bukowski's leadership, will help provide insight across a variety of therapeutic areas and set strategic goals for the...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related